Malaria chemoprophylaxis

From IDWiki
Revision as of 14:22, 1 October 2020 by Aidan (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Background

  • Chemoprophylaxis is recommended for travelers to endemic areas
  • Agent chosen based on the local drug-resistance, patient age, and pregnancy status
  • Also need to focus on personal protective measures such as bed nets, long-sleeved clothing, and insect repellant

Chemoprophylaxis Selection

Chloroquine-Sensitive Regions

Chloroquine-Resistant Regions

  • Regions include most of sub-Saharan Africa, South America, Oceania and Asia
    • See the CATMAT list for specific countries
    • Some areas of Thailand, Myanmar (Burma), Laos and Cambodia, and southern Vietnam are both chloroquine-resistant and mefloquine-resistant
  • Drugs of choice

Chloroquine- and Mefloquine-Resistant Regions

  • Regions include Asia, Africa and the Amazon basin, specifically in rural, wooded regions on the Thai borders with Myanmar, Cambodia, and Laos, as well as in southern Vietnam
  • Drugs of choice

Pregnancy

  • Mefloquine can be used, if they cannot avoid travelling to malaria-endemic areas
    • Can cause neuropsychiatric symptoms
  • Atovaquone-proguanil may be considered after the first trimester

Chemoprophylaxis Doses

  • Note that the medications that require 4 weeks after end of exposure are extended in this way because they do not treat the liver stage
Medication Dose Start Stop
Atovaquone-proguanil 250 mg-100 mg po daily 1 day before 1 week after
Doxycycline 100 mg po daily 1 day before 4 weeks after
Mefloquine 250 mg po weekly 1-3 weeks before 4 weeks after
Primaquine 30 mg base po daily 1 day before 1 week after
Chloroquine 300 mg po weekly 1 week before 4 weeks after
Hydroxychloroquine 310 mg base po weekly 1 week before 4 weeks after